About Us
We’re on a mission to make cancer more detectable.
Our mission is to provide medical professionals the tools
to make better, more informed decisions for better patient outcomes.
Early detection saves lives
Imagion is the 1st-mover expanding biomedical access and application impact of SPIONS (superparamagnetic iron oxide nanoparticles).
By combining high-sensitivity imaging technologies with our innovative biomedically safe nanoparticles, MagSense® technology, we aim to improve clinicians’ ability to visualize tumors and metastases with standard MRI instruments.
aNANOtation
WHAT ARE SPIONS?
Superparamagnetic iron oxide nanoparticles (SPIONs) are tiny, biocompatible particles that exert a local magnetic force in response to the pulsed magnetic field of the MRI, making them ideal for non-invasive detection with standard diagnostic imaging. They can be used for diagnostics, therapy, and tracking of cells within the body, offering a versatile and promising tool in biomedicine.
Get involved with our proprietary nanoparticles
Diagnostic Imaging
MagSense® imaging agents can be developed for many types of solid tumors and can be used at multiple stages of diagnosis including primary diagnosis, staging, and prognosis of diseases.
Other Biomedical Applications
We supply nanoparticles that can be used in third-party branded products across hyperthermia, human and animal vaccines, and cancer screening and treatments.
Purchase SPIONS
We sell our superparamagnetic iron oxide PrecisionMRX® nanoparticles to institutions for research purposes.
Multiple coatings types are available.
Why you should use our PrecisionMRX® magnetic nanoparticles for your biomedical applications
We have developed proprietary methods for making magnetic nanoparticles that enable precise control of key attributes, such as size, size-dispersity, and magnetic properties, that are differentiating for many biomedical applications.
Meet our team of Imagioneers
Geoff Hollis
CFO & Company Secretary
Marie Zhang, PhD
VP Research & Preclinical Development
Elana Levin
Director of Quality Assurance
Carmen Solkowski
Director of Operations
Mee Wa Wong, PhD
Director of Product Market Development
Sormeh Mahjouri
Program Director
Koushik Govindarajan
Clinical Scientist
Nitika Neha
Clinical Trial Manager
Eric Smith-Nguyen
Sr. Research Associate
Hannah Campbell
Senior Accountant
Casie Ost
Marketing Communications Manager
Michael Shun
Nanoparticle Production Tech
Kevin Forero
Nanoparticle Production Tech
Recent Milestones
Drive a discovery & development engine
Approaching MagSense® Partnerships
Imagion Biosystems is actively seeking strategic partners to accelerate the development of our nanoparticles by leveraging the unique capabilities of each company.
MagSense® products are disruptive – enabling molecular MRI:
- Primary diagnosis
- Primary staging & treatment planning
- Companion diagnostics
World class scientific collaborations & partnerships
“Since working with Imagion Biosystems for the last few years, we’ve been able to incorporate their iron oxide nanoparticles into our hyperthermia therapeutic platform. The consistent high quality of the iron oxide nanoparticles has allowed us to ramp up our preclinical testing and move us towards human clinical trials."
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.